Adams Kendra

Insider CIK 1991929 · CCCC Chief Financial Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
CCCC C4 Therapeutics, Inc.	M Exercise	2026-09-18	2026-09-21	6,250	—	$0	385,098	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2026-09-18	2026-09-21	2,775	$3.39	$9.4K	382,323	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2026-09-18	2026-09-21	2,775	$3.39	$9.4K	382,323	SEC↗
CCCC C4 Therapeutics, Inc.	M Exercise	2026-09-18	2026-09-21	6,250	—	$0	385,098	SEC↗
CCCC C4 Therapeutics, Inc.	M Exercise	2026-02-14	2026-02-18	30,950	—	$0	400,479	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2026-02-14	2026-02-18	15,381	$1.89	$29.1K	385,098	SEC↗
CCCC C4 Therapeutics, Inc.	M Exercise	2026-02-13	2026-02-18	3,750	—	$0	402,342	SEC↗
CCCC C4 Therapeutics, Inc.	A Award	2026-02-13	2026-02-18	240,000	—	$0	402,342	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2026-02-13	2026-02-18	1,863	$1.89	$3.5K	400,479	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2025-09-18	2025-09-19	2,775	$3.32	$9.2K	162,342	SEC↗
CCCC C4 Therapeutics, Inc.	M Exercise	2025-09-18	2025-09-19	6,250	—	$0	165,117	SEC↗
CCCC C4 Therapeutics, Inc.	A Award deriv	2025-02-14	2025-02-18	130,600	—	$0	130,600	SEC↗
CCCC C4 Therapeutics, Inc.	A Award	2025-02-14	2025-02-18	87,100	—	$0	169,676	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2025-02-14	2025-02-18	4,559	$3.18	$14.5K	165,117	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2025-02-13	2025-02-18	1,863	$3.20	$6.0K	82,576	SEC↗
CCCC C4 Therapeutics, Inc.	M Exercise deriv	2024-11-07	2024-11-12	3,750	—	$0	10,500	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2024-11-07	2024-11-12	1,102	$6.04	$6.7K	84,439	SEC↗
CCCC C4 Therapeutics, Inc.	M Exercise	2024-11-07	2024-11-12	3,750	—	$0	85,541	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2024-09-18	2024-09-20	1,837	$6.38	$11.7K	81,791	SEC↗
CCCC C4 Therapeutics, Inc.	M Exercise deriv	2024-09-16	2024-09-17	2,250	—	$0	14,250	SEC↗
CCCC C4 Therapeutics, Inc.	M Exercise	2024-09-16	2024-09-17	2,250	—	$0	84,289	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2024-09-16	2024-09-17	661	$6.36	$4.2K	83,628	SEC↗
CCCC C4 Therapeutics, Inc.	D To issuer deriv	2024-03-07	2024-03-08	45,000	—	$0	0	SEC↗
CCCC C4 Therapeutics, Inc.	A Award deriv	2024-03-07	2024-03-08	45,000	—	$0	45,000	SEC↗
CCCC C4 Therapeutics, Inc.	A Award deriv	2024-02-14	2024-02-15	165,300	—	$0	165,300	SEC↗
CCCC C4 Therapeutics, Inc.	A Award	2024-02-14	2024-02-15	36,700	—	$0	82,039	SEC↗
CCCC C4 Therapeutics, Inc.	F Tax w/h	2024-02-13	2024-02-15	1,301	$6.53	$8.5K	45,339	SEC↗
CCCC C4 Therapeutics, Inc.	A Award deriv	2023-09-18	2023-09-19	111,000	—	$0	111,000	SEC↗
CCCC C4 Therapeutics, Inc.	A Award	2023-09-18	2023-09-19	25,000	—	$0	46,640	SEC↗